Estimating Population Cause-Specific Mortality Fractions from in-Hospital Mortality: Validation of a New Method by Lopez, Alan D et al.
 
Estimating Population Cause-Specific Mortality Fractions from in-
Hospital Mortality: Validation of a New Method
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Murray, Christopher J. L., Alan D. Lopez, Jeremy T. Barofsky,
Chloe Bryson-Cahn, and Rafael Lozano. 2007. Estimating
population cause-specific mortality fractions from in-hospital
mortality: validation of a new method. PLoS Medicine 4(11):
e326.
Published Version doi:10.1371/journal.pmed.0040326
Accessed February 19, 2015 1:27:01 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:4595362
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAEstimating Population Cause-Specific
Mortality Fractions from in-Hospital Mortality:
Validation of a New Method
Christopher J. L. Murray
1*, Alan D. Lopez
2, Jeremy T. Barofsky
3, Chloe Bryson-Cahn
3, Rafael Lozano
4
1 Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, United States of America, 2 School of Population Health, University of
Queensland, Herston, Queensland, Australia, 3 Harvard Initiative for Global Health, Cambridge, Massachusetts, United States of America, 4 Director General de Informacio ´n,
Secreterı ´a de Salud, Mexico DF, Mexico
Funding: This project was funded, in
part, through the Grand Challenges
in Global Health Initiative (http://
www.gcgh.org/channels/gcgh). This
project was also funded in part by
US National Institute on Aging grant
# PO1 AG17625 ‘‘Global Burden of
Disease 2000 in Aging Populations.’’
The funders had no role in study
design, data collection and analysis,
decision to publish, or preparation
of the manuscript.
Competing Interests: The authors
have declared that no competing
interests exist.
Academic Editor: Peter Byass, Umea ˚
University, Sweden
Citation: Murray CJL, Lopez AD,
Barofsky JT, Bryson-Cahn C, Lozano R
(2007) Estimating population cause-
specific mortality fractions from in-
hospital mortality: Validation of a
new method. PLoS Med 4(11): e326.
doi:10.1371/journal.pmed.0040326
Received: May 21, 2007
Accepted: October 1, 2007
Published: November 20, 2007
Copyright:  2007 Murray et al. This
is an open-access article distributed
under the terms of the Creative
Commons Attribution License, which
permits unrestricted use,
distribution, and reproduction in any
medium, provided the original
author and source are credited.
Abbreviations: ARE, average
relative error; CSMF, cause-specific
mortality fraction; ICD, International
Classification of Diseases; VA, verbal
autopsy; VR, vital registration
* To whom correspondence should
be addressed. E-mail: cjlm@u.
washington.edu
ABSTRACT
Background
Cause-of-death data for many developing countries are not available. Information on deaths
in hospital by cause is available in many low- and middle-income countries but is not a
representative sample of deaths in the population. We propose a method to estimate
population cause-specific mortality fractions (CSMFs) using data already collected in many
middle-income and some low-income developing nations, yet rarely used: in-hospital death
records.
Methods and Findings
For a given cause of death, a community’s hospital deaths are equal to total community
deaths multiplied by the proportion of deaths occurring in hospital. If we can estimate the
proportion dying in hospital, we can estimate the proportion dying in the population using
deaths in hospital. We propose to estimate the proportion of deaths for an age, sex, and cause
group that die in hospital from the subset of the population where vital registration systems
function or from another population. We evaluated our method using nearly complete vital
registration (VR) data from Mexico 1998–2005, which records whether a death occurred in a
hospital. In this validation test, we used 45 disease categories. We validated our method in two
ways: nationally and between communities. First, we investigated how the method’s accuracy
changes as we decrease the amount of Mexican VR used to estimate the proportion of each
age, sex, and cause group dying in hospital. Decreasing VR data used for this first step from
100% to 9% produces only a 12% maximum relative error between estimated and true CSMFs.
Even if Mexico collected full VR information only in its capital city with 9% of its population, our
estimation method would produce an average relative error in CSMFs across the 45 causes of
just over 10%. Second, we used VR data for the capital zone (Distrito Federal and Estado de
Mexico) and estimated CSMFs for the three lowest-development states. Our estimation method
gave an average relative error of 20%, 23%, and 31% for Guerrero, Chiapas, and Oaxaca,
respectively.
Conclusions
Where accurate International Classification of Diseases (ICD)-coded cause-of-death data are
available for deaths in hospital and for VR covering a subset of the population, we
demonstrated that population CSMFs can be estimated with low average error. In addition, we
showed in the case of Mexico that this method can substantially reduce error from biased
hospital data, even when applied to areas with widely different levels of development. For
countries with ICD-coded deaths in hospital, this method potentially allows the use of existing
data to inform health policy.
The Editors’ Summary of this article follows the references.
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Reliable information on the leading causes of death in
populations and how this death structure changes is a key
element of the evidence base to guide health policies and
programs. The relative speed of mortality decline for major
diseases and injuries, or even reversals of mortality decline
such as that observed in Africa [1–3], Eastern Europe [4,5],
and parts of Asia [6], are more competently addressed in
terms of public policy responses with reliable information on
cause-of-death trends. Yet, despite the critical importance of
population data for causes of death, availability of such data
in many countries is limited. For the developing world as a
whole, only about 25% of deaths are recorded by vital
registration (VR) systems; in the poorest countries, this ﬁgure
is closer to 5%–10% [7,8]. Recognition of the importance of
good cause-of-death data for public health monitoring, even
in the poorest countries, has led to increased interest in
verbal autopsy (VA) as a tool for measuring population cause-
speciﬁc mortality fractions (CSMFs) [9–12]. While this
increased focus on VA methods and applications is welcome,
current knowledge and practices need to be strengthened to
improve scientiﬁc validity. For example, we have proposed a
new method for assigning causes of death using VA data that
does not depend on physician review and provides more
accurate population CSMFs, as well as individual cause of
death assignments [13]. Even if standardized instruments for
VA were to be widely adopted, and methodological improve-
ments systematically applied to enhance comparability of
results, population VA data would still require new data
collection through either household surveys or demographic
sample surveillance systems.
Many poor nations already collect data that in fact can be
used to measure population CSMFs, namely in-hospital
deaths where the underlying cause of death has been coded
according to the International Classiﬁcation of Diseases
(ICD). For example, publications from ministries of health
and research studies report on mortality in hospital coded by
the ICD in at least 18 sub-Saharan African countries [14–31];
essentially all countries in Latin America and many in the
Caribbean also report in-hospital deaths [32–34]. While these
data are extensively collected in poor countries, they are
rarely used for population cause-of-death monitoring since
they are likely to be highly biased. Deaths in hospital are not a
random sample of deaths in the community. Some categories
of individuals such as the rich or more educated are more
likely to die in hospital, and causes of death among the rich
are likely to be different than among the poor. Furthermore,
deaths that occur in hospital are likely to be affected by the
natural history of disease or injury. Motor vehicle accident
deaths are less likely to occur in hospital than obstructed
labor deaths, for example. The probability of dying in
hospital is also likely to be a function of physical, ﬁnancial,
and cultural access to hospital services.
Previous studies have shown that in low-income settings VR
systems capture only a small fraction of deaths in the
community [8,35–38]. Arudo et al. [39] compared vital
registration causes of death in rural Kenya with the results
of VA in children and found substantial differences in causes
of death. Whiting et al. [40] found that causes of death in
hospital were similar to those detected using VA for the
population over age 5 y. These prior attempts to use VR and/
or hospital death data have not attempted to address the
problem that deaths in hospital are not a representative
sample of all deaths.
In this paper, we propose a method to obtain relatively
accurate CSMFs for the population using CSMFs from in-
hospital deaths. The basis of the method is the use of
observed proportions of in-hospital death by age–sex–cause
group to correct observed hospital CSMFs, yielding robust
estimates of population CSMFs. To validate our method, we
used vital registration data from Mexico for the years 1998–
2005. We also explored the extent to which applying
probabilities of in-hospital death in one population could
be used to estimate population CSMFs in another.
Methods
The Model and Definitions
We begin with the following deﬁnitions:
Hasj ¼ DasjPasj ð1Þ
where Hasj is the number of deaths in hospital for age group a,
sex s from cause j, Dasj is the number of population deaths in
age group a, sex s from cause j, and Pasj is the proportion of
deaths in age group a, sex s from cause j that occur in hospital.
In addition, the population cause-speciﬁc mortality fraction
is simply the number of deaths from cause j divided by all
deaths:
CSMFj ¼
X l
a¼0
X 2
s¼1
Dasj
X l
a¼0
X 2
s¼1
X k
j¼1
Dasj
ð2Þ
It follows from Equation 1 that we can estimate deaths
from cause j in an age–sex group by dividing hospital deaths
by the proportion of deaths that are expected to occur in
hospital:
CSMFj ¼
X l
a¼0
X 2
s¼1
Hasj
Pasj
X l
a¼0
X 2
s¼1
X k
j¼1
Hasj
Pasj
ð3Þ
If we are able to estimate the values of Pasj for a population,
then in-hospital deaths can be easily corrected to yield
population CSMFs.
To operationalize Equation 3, we require two information
sources: (a) deaths in hospital by age and sex accurately
assigned an underlying cause of death according to the ICD
[41], and (b) an estimate of the proportion of in-hospital
death by age, sex, and cause group, values of Pasj obtained
from a subset of that population or a similar population in
another country. Nearly all middle-income and many low-
income countries record in-hospital deaths by cause, and in a
number of them the cause attribution may be of sufﬁciently
high quality to obtain more detailed data that would allow
tabulation by age, sex, and cause. The challenge for
operationalizing this method is to obtain a reasonable
estimate of Pasj. Estimates of Pasj can only be obtained where
complete or near-complete VR systems are available that
accurately assign the underlying cause of death and whether
the death occurred in hospital. In countries that have
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Population CSMF from Hospital Datacomplete VR systems for the whole country, estimating
CSMFs using Equation 3 is not necessary, because the VR
system will directly yield population CSMFs. For countries
without complete VR systems, however, there may be a
functioning VR system for a particular subset of the
population such as urban areas, or selected states and
provinces. These partial VR data can be used to estimate Pasj
values if the death certiﬁcate also includes information on
whether the death occurred in hospital. In this way our
method allows estimation of population CSMFs from in-
hospital deaths. The strength of this approach depends on the
accuracy of Pasj estimates for a subset of the population or
some other community. This accuracy in turn depends on
how stable Pasj values are across communities with different
socioeconomic levels and over time. In this study, we use
complete VR data for Mexico, which includes whether a death
occurred in hospital, to test whether various approaches to
estimating Pasj values based on partial VR data provide robust
estimates of CSMFs.
Validation
We validated this approach using individual death records
from Mexico 1998–2005 (see Table 1). Vital registration is
estimated to be over 90% complete in Mexico and closer to
95% complete for adults [8]. Mexico collects information on
the location of death (in-hospital or not), so that we can use
in-hospital deaths in Mexico to assess whether our predicted
population CSMFs are close to the observed population
CSMFs from the vital registration data. Of the more than
450,000 deaths in Mexico in 2005, 44% occurred in hospital
and 56% out of the hospital. Overall, 97% of deaths were
certiﬁed by a doctor and of those, 29% were certiﬁed by the
attending doctor, 14% by a forensic scientist, and 57% by
another doctor. Of those deaths occurring outside the
hospital, 30% were certiﬁed by the attending physician,
19% by a forensic scientist, 47% by other doctors, and 4% by
non-doctors.
Mexico’s states also represent a tremendous range of
socioeconomic and health conditions. For example, the states
of Nuevo Leon and the Federal District have higher
purchasing power parity-adjusted per capita GDP than
Portugal or Greece, whereas the poorest Mexican states like
Oaxaca and Chiapas have PPP-adjusted per capita GDP lower
than Swaziland and Cape Verde [42,43]. Infant mortality
ranges from almost 30 per 1,000 live births in Chiapas and
Oaxaca—higher than Cape Verde—to around 14 in states
such as Nuevo Leon and Distrito Federal, rates close to
Bulgaria and Romania [44,45]. Moreover, the Mexican state of
Guerrero has a higher maternal mortality ratio (MMR) than
Botswana, whereas the Mexican state of Colima has a lower
MMR than France [46,47]. Mexico may therefore be used to
test the applicability of this approach for a wide range of
developing countries.
We based our analysis on 45 cause groups that are mutually
exclusive and collectively exhaustive. To determine these, we
started with the Global Burden of Disease cause list adjusted
to the U.S. cause-of-death proﬁle, which includes 109 causes
[48]. The GBD cause list maps the entire detailed three- and
four-digit ICD codes into a more manageable set of cause
clusters that are relevant to public health decision-making;
this cause list is used by WHO for annual reporting of causes
of death [49]. To avoid including small causes of death that
might be subject to large sampling errors, we included only
causes that account for more than 0.5% of deaths, except for
a composite category ‘‘other communicable and maternal
conditions’’ which represents 0.41% of all deaths. All other
deaths were grouped into broad-cause residual categories
which preserve the basic Global Burden of Disease (GBD)
cause structure and yield 45 cause groups (see Table 2,
ordered by percent of total deaths, and Table S1). Compared
to other published VA validation studies, this is a very
detailed set of causes to evaluate [11,12].
Our primary measure of method validity is the average
relative error (ARE) for the 45 CSMFs. This metric can be
calculated for any population for which CSMFs are being
predicted. Formally, it is deﬁned as:
ARE ¼
X j¼45
j¼1
jðCSM ^Fj=CSMFjÞ 1j
45
ð4Þ
where CSMFj is the observed population CSMF for cause j,
and CSMF^
j is the predicted CSMF. This metric directly
measures the deviation between estimated and true CSMFs.
Sensitivity and speciﬁcity for an individual cause of death
cannot be measured, as this method only generates popula-
tion CSMFs.
We tested this approach in two ways. First, we demon-
strated that the method can provide good estimates of
population CSMFs using a range of hypothetical coverage of
national vital registration data. The values of Pasj for a
country can be estimated using the available VR data in a
country. We simulated partial VR coverage in Mexico by
using VR data from the most socioeconomically advanced
states and progressively adding lower socioeconomic-status
states. We ordered states on the basis of the literacy rate from
the 2000 Census. We have tested alternative ways of ordering
states such as by income, and these changes have not had a
qualitative effect on the results. In other words, we assumed
that most VR data come from the more developed parts of
the country, especially in nations with low levels of VR
coverage. For each level of partial VR coverage, we computed
new Pasj estimates and used this set of probabilities to correct
Mexico’s hospital CSMFs to estimate population CSMFs. Even
based on an analysis of nearly 3.5 million deaths, we
examined 45 causes-of-death by 20 age groups, by sex, so
that some of these groups have small numbers. Consequently,
we set the probability of in-hospital death to zero for those
groups with fewer than three total deaths.
Table 1. Descriptive Statistics for Vital Registration Death Data in
Mexico 1998–2005
Statistic Number
Total count of deaths 3,489,717
Mean age at death 58.47 y
Deaths at 80þ y of age 24.54%
Deaths at , 1 y of age 8.06%
Female 44.97%
Deaths in hospital 46.44%
Illiterate, mean 9.20%
doi:10.1371/journal.pmed.0040326.t001
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Population CSMF from Hospital DataSecond, we explored whether Pasj values measured in one
population can be used to estimate population CSMFs using
in-hospital deaths in another community. We used VR data
for 1998–2005 for the Distrito Federal and the Estado de
Mexico, which together form the main urban and periurban
center in Mexico, to calculate Pasj values. We would expect
that an urban area such as these two together would have
higher access to hospital services than a poor rural area. We
then applied these fractions of in-hospital deaths to the three
poorest states in Mexico: Oaxaca, Chiapas, and Guerrero. The
difference between the capital city area and these states in
terms of income, educational attainment, and access to
hospital services is quite marked, making this a strong test
of the generalizability of the method to other countries where
values of Pasj would need to be estimated from data in a
neighboring country.
Results
Table 2 summarizes the average, minimum, and maximum
proportion of in-hospital deaths for all 45 causes in all 32
states in Mexico. Perinatal infections represent the cause of
death with the highest average proportion of deaths that
occur within a hospital at 94%, while the average proportion
for the intentional-injuries group is the lowest at 25%. Across
states and causes, the proportion of in-hospital deaths varies
from 7% for nutritional deﬁciencies to 100% for perinatal
infections. Figures 1–4 show how the in-hospital fraction of
death differs by age group and cause. The ﬁgures also show
Table 2. The Average, Minimum, and Maximum Fraction of in-Hospital Deaths for All 45 Causes in All States in Mexico 1998–2005
Cause
a Average % of Deaths
in-Hospital For All States
Maximum State % of
Deaths in-Hospital
Minimum State % of
Deaths in-Hospital
% of Total
Deaths
Diabetes mellitus 53.54 71.01 30.74 11.94
Ischemic heart disease 37.84 50.84 16.85 10.43
Cerebrovascular disease 54.09 74.82 26.13 5.84
Appendicitis 53.31 84.37 19.92 5.48
Other unintentional injuries 41.61 54.26 25.99 4.65
Other cardiovascular diseases 44.88 63.10 18.10 4.19
Chronic obstructive pulmonary disease 44.29 65.46 17.05 3.84
Lower respiratory infections 46.86 69.35 19.35 3.24
Other malignant neoplasms 50.37 68.71 29.26 3.22
Other digestive diseases 73.32 88.57 42.15 2.91
Intentional injuries 24.68 34.38 18.12 2.77
Nutritional deficiencies 29.10 61.35 6.70 2.66
Hypertensive diseases 42.93 70.71 14.83 2.38
Road traffic accidents 37.10 52.24 21.64 2.31
Nephritis and nephrosis 54.75 80.16 21.42 2.27
Perinatal respiratory disorders 88.51 98.94 67.90 2.04
Ill-defined malignant neoplasms 39.86 59.84 20.28 2.01
Breast and cervical cancer 35.80 57.58 14.61 1.84
Other respiratory diseases 46.59 70.09 21.10 1.76
Ill-defined causes 11.71 30.67 2.27 1.76
Other neuropsychiatric conditions 40.97 56.84 18.43 1.72
Other noncommunicable disease 52.06 78.75 20.35 1.59
Lung cancer 37.67 55.97 18.81 1.46
Endocrine disorders 58.13 74.21 31.21 1.28
Stomach cancer 29.35 53.15 10.58 1.13
Other congenital anomalies 79.09 92.00 54.22 1.13
Diarrheal diseases 51.47 77.53 13.98 1.06
HIV 61.68 81.37 35.92 0.98
Liver cancer 30.18 53.10 13.03 0.98
Congenital heart anomalies 79.29 92.79 45.77 0.95
Prostate cancer 27.24 48.74 10.59 0.93
Alcohol use 33.66 61.02 15.54 0.86
Other infectious and parasitic diseases 72.56 90.59 47.14 0.84
Septicemia 81.99 94.26 53.76 0.76
Tuberculosis 57.16 81.45 28.60 0.75
Low birth weight, birth asphyxia, birth trauma 87.73 98.62 62.31 0.74
Perinatal infections 94.27 99.74 78.67 0.66
Other neoplasms 63.72 84.77 35.21 0.64
Pancreas cancer 35.88 57.44 16.72 0.64
Colorectal cancer 37.49 57.12 18.92 0.63
Cirrhosis of the liver 50.17 77.41 16.18 0.63
Other perinatal conditions 86.96 98.50 61.74 0.58
Hematemesis, melena, and gastrointestinal hemorrhage 70.80 88.69 41.71 0.56
Ill-defined injuries 36.84 55.17 22.03 0.56
Other communicable and maternal conditions 69.85 89.10 41.35 0.41
aCauses are listed by the percentage of total deaths.
doi:10.1371/journal.pmed.0040326.t002
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Population CSMF from Hospital Datathe fractions dying in hospital for four subgroups of the
Mexican population created by dividing the population into
four groups on the basis of population literacy. These
subgroups serve to demonstrate how socioeconomic status
affects the overall probability of dying in hospital. For HIV/
AIDS, diabetes mellitus, and cerebrovascular disease, the
proportion dying in hospital at any age group is lower in
municipalities with lower socioeconomic status as indicated
by literacy rates. For road trafﬁc accidents, however, there is
no marked difference by literacy status in the proportion of
in-hospital deaths, as might be expected. Diabetes and
cerebrovascular diseases show a generally declining propor-
tion of deaths in hospital as a function of age. There is a
weaker trend by age for HIV/AIDS and the proportion dying
in hospital increases slightly for road trafﬁc accidents. These
four causes illustrate that the proportion of in-hospital
deaths is a distinct function of age, cause, and level of
community development. This diverse pattern conﬁrms that
CSMFs based solely on in-hospital deaths are likely to be
inaccurate.
Indeed, Figure 5 demonstrates the inaccurate nature of
hospital CSMFs when used without correction to estimate
Figure 1. Proportion of HIV/AIDS Deaths That Were in Hospitals, versus Age Group, According to Community Literacy Quartiles, Mexico 1998–2005
Data are means and 95% confidence intervals.
doi:10.1371/journal.pmed.0040326.g001
Figure 2. Proportion of Diabetes Deaths That Were in Hospitals, versus Age Group, According to Community Literacy Quartiles, Mexico 1998–2005
Data are means and 95% confidence intervals.
doi:10.1371/journal.pmed.0040326.g002
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Population CSMF from Hospital Datapopulation CSMFs. The ﬁgure shows average relative error
for hospital CSMFs as a function of the percentage of deaths
in-hospital for each Mexican state. As expected, the average
percent error steadily rises as the proportion of deaths in
hospital falls. In other words, in states with a smaller
proportion of in-hospital deaths, the effects of selection bias
on the hospital CSMFs are greatest. Speciﬁcally, average error
ranges from 25% in the most developed states in the north of
Mexico to 50% to 60% in the least-developed communities of
Chiapas and Oaxaca where the proportion of deaths that
occur in hospitals is less than 30%. The data in Figure 5
provide strong empirical validation for the hypothesis that,
without correction, hospital CSMFs in poor communities are
highly inaccurate. The relationship between error and
percent of in-hospital deaths appears to be nearly linear.
Figure 6 systematically explores the relationship between
the amount of VR data used to calculate the Pasj values in
Mexico (from 9% to 100%) and the average relative error
Figure 3. Proportion of Cerebrovascular Disease Deaths That Were in Hospitals, versus Age Group, According to Community Literacy Quartiles, Mexico
1998–2005
Data are means and 95% confidence intervals.
doi:10.1371/journal.pmed.0040326.g003
Figure 4. Proportion of Road Traffic Accident Deaths That Were in Hospitals, versus Age Group, According to Community Literacy Quartiles, Mexico
1998–2005
Data are means and 95% confidence intervals.
doi:10.1371/journal.pmed.0040326.g004
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Population CSMF from Hospital Dataacross 45 causes of death at the national level. When 100% of
VR data is used, by deﬁnition, the Pasj values are correct and
ARE is zero. As the proportion of deaths used to estimate the
Pasj values drops, ARE increases. Nevertheless, ARE based on
9% to 35% of all deaths captured in the VR system ranges
from only 10% to a maximum of 12%. For comparison,
Figure 6 also shows ARE if in-hospital deaths were used to
estimate population CSMFs without correction, at the
national level, namely 33%. The conclusion emerging from
Figure 6 is that even if VR in Mexico covered only a small
fraction of the country’s most developed states, our methods
suggest that we would be able to measure CSMFs quite
Figure 5. Average Relative Error in Population CSMFs when Based on Hospital CSMFs by State versus the Proportion of All Deaths Occurring in-Hospital,
Mexico 1998–2005
Each point represents a state in Mexico.
Legend: Ags, Aguascalientes; BC, Baja California; BCS, Baja California Sur; Camp, Campeche; Chih, Chihuahua; Chis, Chiapas; Coah, Coahuila de Zaragoza;
Col, Colima; DF, Distrito Federal; Dgo, Durango; EDOMEX, Estado de Mexico; GRo, Guerrero; Gto, Guanajuato; Hgo, Hidalgo; Jal, Jalisco; Mich, Michoacan
de Ocampo; Mor, Morelos; Nay, Nayarit; NL, Nuevo Leon;Oax, Oaxaca; Pue, Puebla; Qro, Queretaro de Arteaga; QRoo, Quintana Roo; Sin, Sinaloa; SLP,
San Luis Potosi; Son, Sonora; Tab, Tabasco; Tamp, Tamaulipas; Tlax, Tlaxcala; Ver, Veracruz-Llave; Yuc, Yucatan; Zac, Zacatecas.
doi:10.1371/journal.pmed.0040326.g005
Figure 6. Population CSMFs Average Relative Error for 45 Cause Groups
ARE was calculated as a function of the percentage of Mexican VR data used to assess the proportion of deaths in each age, sex, and cause group dying
in hospital.
doi:10.1371/journal.pmed.0040326.g006
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Population CSMF from Hospital Dataaccurately if data on causes of death in hospital were
available. We hypothesize that ARE remains relatively stable
when we estimate population CSMFs using between 9% and
35% of Mexico’s VR data because the better-off states may
have a similar hospitalization pattern, so that adding further
data does not substantially affect Pasj. Using only 9% of deaths
(from Distrito Federal), Table 3 compares the average
difference over states between true and predicted CSMFs,
where predicted CSMFs are calculated from hospital data or
using the method described in Equation 3. The average
difference is closer to zero for most, but not all causes of
death; moving from  1.4% to  0.79% for diabetes and from
0.55% to  0.13% for road trafﬁc accidents, but increasing
slightly for lower respiratory disease. The interquartile range
in the difference between true and predicted CSMFs using
our method varies widely over states for other unintentional
injuries (from  0.54% to 0.94%), but varies little for causes
such as other neoplasms and gastrointestinal hemorrhage.
Using VR data from the capital city and surrounding
communities (Distrito Federal and Estado de Mexico) to
estimate the Pasj, Figure 7 demonstrates what would be the
ARE for the three least developed states in Mexico. In the
state with the lowest fraction of deaths in hospital, Oaxaca,
the ARE is 30% using our correction method. The ARE across
the 45 CSMFs is even lower for the states of Guerrero and
Chiapas. While these levels of error are much higher than we
Table 3. The Average, 25th, and 75th Percentile Difference over States between True and Predicted CSMFs Using Hospital Data and
the Correction Method from Equation 3
Cause
a CSMFs Predicted
with Hospital
Data (%)
25th
Percentile
(%)
75th
Percentile
(%)
CSMFs
predicted from
Equation 3 (%)
25th
Percentile
(%)
75th
Percentile
(%)
Diabetes mellitus  1.40  1.83  0.97  0.79  1.15  0.38
Ischemic heart disease 2.19 1.67 2.71  1.58  2.01  1.15
Cerebrovascular disease  0.72  1.00  0.44 0.46 0.18 0.65
Appendicitis  0.23  0.86 0.20 0.08  0.47 0.47
Other unintentional injuries 0.53 0.03 1.05 0.18  0.54 0.94
Other cardiovascular diseases 0.32 0.01 0.58 0.79 0.58 0.99
Chronic obstructive pulmonary disease 0.32 0.09 0.64 0.11  0.12 0.46
Lower respiratory infections 0.19  0.19 0.35  0.35  0.50  0.12
Other malignant neoplasms  0.20  0.31  0.05  0.13  0.26  0.05
Other digestive diseases  1.54  1.89  1.21  0.12  0.36 0.06
Intentional injuries 1.29 0.72 1.66  0.13  0.64 0.70
Nutritional deficiencies 1.26 0.47 1.90 0.70  0.04 1.35
Hypertensive diseases 0.29 0.08 0.48 0.31 0.10 0.47
Road traffic accidents 0.55 0.04 1.04  0.13  0.61 0.57
Nephritis and nephrosis  0.27  0.44  0.14  0.03  0.19 0.06
Perinatal respiratory disorders  1.84  2.28  1.14  0.37  0.71 0.02
Ill-defined malignant neoplasms 0.36 0.22 0.49  0.09  0.26 0.05
Breast and cervical cancer 0.49 0.35 0.60 0.05  0.10 0.18
Other respiratory diseases 0.06  0.06 0.15 0.12 0.04 0.19
Ill-defined causes 1.59 0.85 1.91 1.15 0.45 1.37
Other neuropsychiatric conditions 0.26 0.17 0.34 0.03  0.05 0.14
Other noncommunicable disease  0.11  0.24 0.00 0.26 0.13 0.37
Lung cancer 0.34 0.21 0.46  0.21  0.39  0.03
Endocrine disorders  0.30  0.36  0.22  0.02  0.10 0.06
Stomach cancer 0.49 0.33 0.59 0.10  0.05 0.26
Other congenital anomalies  0.78  0.97  0.55  0.17  0.29  0.02
Diarrheal diseases 0.05  0.13  0.01 0.08  0.10 0.00
HIV  0.29  0.39  0.18 0.02  0.04 0.09
Liver cancer 0.39 0.27 0.51 0.12 0.00 0.27
Congenital heart anomalies  0.65  0.77  0.46  0.14  0.25  0.03
Prostate cancer 0.43 0.32 0.52 0.03  0.12 0.17
Alcohol use 0.28 0.09 0.42 0.17 0.01 0.32
Other infectious and parasitic diseases  0.46  0.53  0.36  0.08  0.14  0.01
Septicemia  0.58  0.64  0.44  0.06  0.13 0.04
Tuberculosis  0.14  0.18  0.08 0.11 0.02 0.16
Low birth weight, birth asphyxia, birth trauma  0.68  0.91  0.38  0.11  0.18 0.03
Perinatal infections  0.70  0.95  0.38  0.14  0.22 0.01
Other neoplasms  0.22  0.28  0.17 0.00  0.02 0.03
Pancreas cancer 0.16 0.09 0.21  0.02  0.10 0.03
Colorectal cancer 0.13 0.09 0.17  0.07  0.14 0.00
Cirrhosis of the liver 0.01  0.09 0.10 0.12 0.02 0.21
Other perinatal conditions  0.49  0.60  0.31  0.09  0.17 0.00
Hematemesis, melena, and gastrointestinal hemorrhage  0.26  0.29  0.22 0.04 0.00 0.07
Ill-defined injuries 0.07 0.01 0.12  0.16  0.26 0.00
Other communicable and maternal conditions  0.20  0.27  0.11  0.01  0.05 0.02
aFor ease of comparison, causes are listed in the same order as in Table 1.
doi:10.1371/journal.pmed.0040326.t003
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Population CSMF from Hospital Dataobtain at the national level, the results still demonstrate the
possibility of estimating plausible CSMFs for a large set of
causes even in settings where the Pasj values cannot be
measured directly, but must be borrowed from another
population.
Discussion
In this paper, we have demonstrated that when high-quality
ICD-coded data on deaths in hospital and high-quality ICD-
coded data from vital registration from a small subset of the
population or a similar population are available, population
CSMFs can be estimated with an acceptable level of error.
The results are robust even when using less than 10% of
Mexico’s VR data to estimate the proportion of in-hospital
death for each age, sex, and cause group. These results are
encouraging; in VA validation studies, in the best of circum-
stances, for much smaller and less detailed cause groups, the
average percent error has been found to be substantially
higher. For example, an adult VA validation study using
physician coded VA found 70% average error over 23 cause
groups in China [12,13]. The average error in this analysis,
with more than twice as many cause groups, is markedly
smaller.
The critical question for national and global mortality
analyses is whether we can generalize this approach to
populations outside Mexico. Given the realities of the quality
of in-hospital death coding and the availability of partial VR
data, we believe there are four distinct scenarios with
different applications of this approach. First, there are a
number of countries, such as the Dominican Republic,
Ecuador, Egypt, El Salvador, Georgia, Guatemala, Haiti,
Honduras, India, Iran, China, Kazakhstan, Tunisia, Morocco,
Algeria, Lebanon, Mozambique, Nicaragua, Peru, Zimbabwe,
Turkey, and Senegal [8,38,50–58], where reasonably accurate
ICD-coded VR data are available for a subset of the
population and in-hospital death data are also available.
For example, in the Indian state of Maharashtra, comparison
of urban death rates from the Sample Registration Scheme
and the medical certiﬁcation of causes of death data suggest
that about 80% of urban deaths are captured [56]. In South
Africa, the vital registration system is believed to capture
about 90% of deaths [2]; this dataset could perhaps serve to
explore how much the values for Pasj differ from Mexican
municipalities at the same level of development. In a similar
fashion, nearly complete vital registration data for the
eastern provinces of China could be used to estimate CSMFs
in the poorer provinces [58]. These are countries where the
approach outlined here may be directly applicable.
Second, there are countries, such as Brazil, Colombia, Costa
Rica, Thailand, or the Philippines, that have VR systems that
are more than 80% complete [8], but often the poorest
communities are not covered and exhibit low-quality cause-
of-death assignment. In these settings, our approach may
have a more limited role in helping assess the population
CSMFs in selected low-income communities.
Third, there are a number of countries in sub-Saharan
Africa and Asia, such as Pakistan, Bangladesh, Indonesia, and
Vietnam, for which deaths in hospital are recorded and
assigned causes according to the ICD, but vital registration
data may not be available. In these settings, it may be
worthwhile using the Pasj values for a neighboring country
(such as India for Pakistan and Bangladesh; or South Africa,
Zimbabwe, or Mozambique for other Southern African
countries) to generate an estimate of the composition of
hospital mortality. Using Pasj values from another country will
clearly be less desirable than estimating them directly for a
national population, but this analysis using deaths recorded
in Mexico’s capital district to estimate CSMFs in poor states
demonstrates that this may still work reasonably well.
Finally, for a number of sub-Saharan African countries,
deaths in hospital may be recorded, but the quality of cause-
of-death attribution in hospital may be poor. In these
circumstances, the method proposed here may not be
productively applied. Rao et al. [58] proposed a number of
criteria such as the fraction of deaths assigned to ill-deﬁned
codes to evaluate the quality of ICD coding. Whiting et al. [40]
demonstrated in Tanzania that it is feasible in these settings
to use physician review of the medical records maintained in
hospitals to assign a more accurate underlying cause of death
according to ICD principles. This is a much more time-
intensive and costly effort compared to using data that are
already recorded in these hospitals. Nevertheless, it may be
worthwhile to invest in physician review of medical records to
strengthen the quality of the ICD assignment of causes of
death, especially if such data can be used to estimate
population CSMFs. This approach also highlights the poten-
tial beneﬁts of increased training for accurate cause-of-death
certiﬁcation in hospitals in low-resource settings.
It seems plausible that, as in Mexico, the proportion of
deaths in hospital in different countries would be a systematic
function of individual covariates (age and sex), cause-of-death
and a set of community factors that inﬂuence physical,
ﬁnancial, and cultural access to hospital services. Figures 1–4
show that the proportion of in-hospital death can differ
signiﬁcantly by literacy level, and future work could inves-
tigate how other community attributes that relate to the use
of hospital services might improve estimates of population
CSMFs. We have investigated using various logistic regression
models of the probability of dying in hospital as a function of
a wide set of individual and community covariates. This work
Figure 7. Population CSMFs Average Relative Error for the Three Least-
Developed Mexican States
Average relative error was estimated on the basis of the proportion of in-
hospital deaths by age, sex, and cause groups observed in Distrito
Federal and Estado de Mexico.
doi:10.1371/journal.pmed.0040326.g007
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Population CSMF from Hospital Datasuggests that further research may yield important insights
into the determinants of dying in hospital that may
strengthen our ability to predict Pasj values in various
populations. It is important in this regard to recognize that,
based on Equation 3, community factors that scale the Pasj
data for all causes in an equal manner have no effect on the
accuracy of this approach. This in part explains why it is
possible to use Pasj values from the capital city region of
Mexico, where 55% of deaths occur in hospital, to estimate
the CSMFs in Oaxaca, where only 25% of deaths occur in
hospital.
We have validated our method using data for only one
country, Mexico. It is clearly important that future research
conﬁrm our ﬁnding that Pasj values are predictable using
partial data or data from other populations. Such future
validation studies can only be conducted in settings where
there is nearly complete vital registration with good-quality
ICD coding. In these settings, investigators will require access
to individual death records to measure Pasj and to further
investigate the determinants of dying in hospital. Such
validation studies will be an important step to build
conﬁdence that the approach we propose can be applied in
the various settings we have outlined. One candidate would
be South Africa, which now has high levels of VR coverage
and a different burden of disease than Mexico, with more
cases of HIV and TB.
We have proposed a method to estimate population CSMFs
using in-hospital deaths. To obtain cause-speciﬁc death rates
or numbers of deaths, age-speciﬁc all-cause (total) mortality
rates need to be derived from some other demographic
source or method [59,60]. CSMFs would then be applied to
these all-cause mortality rates to generate cause-speciﬁc
death rates, the information base most relevant for public
policy. It is beyond the scope of this paper to discuss the
extensive literature on the methods used by demographers to
generate age-speciﬁc death rates from all causes. However, we
recognize that in the long run the best method to generate
both age-speciﬁc death rates from all causes and accurate
death rates by cause is to invest in the development of
national vital registration systems. Development of methods
to estimate population CSMFs, while useful, should not be
taken as an excuse to ignore the strengthening of national
vital registration systems.
This analysis also illustrates the potential of individual-level
death data to generate critical evidence for health policy.
Other studies [61,62] have illustrated how individual death
ﬁles can allow insights and analyses that would otherwise be
impossible. WHO should encourage countries to digitize and
make available to their research communities individual
death records, with appropriate steps to protect privacy [63].
Not only can these data be used to estimate a variety of
population rates and proportions, but they can also permit
further methodological innovation tailored to local needs.
Well-informed, ﬂexible, evidence-based health policies are
more likely to support rapid health development in poor
countries than current practices based largely on anecdotal
or small-scale evidence about how incidence or prevalence of
major diseases is changing. Cause-of-death data have tradi-
tionally been the cornerstone of such an evidence base, yet
current strategies to improve data such as vital registration or
verbal autopsy are unlikely to yield adequate information for
health planning in poor countries in the near future.
Alternative methods are required that can be applied in
conjunction with these approaches to more reliably estimate
the descriptive epidemiology of populations at comparatively
low cost.
Estimates of population CSMFs based on in-hospital
mortality data may provide one more tool in an overall
approach to develop robust cause-of-death estimates for
populations without complete vital registration. The method
proposed here, if more widely applicable in settings with
appropriate quality ICD-coded hospital data, would allow
countries to utilize data already collected on in-hospital
deaths to estimate the population cause-speciﬁc mortality
structure, in combination with verbal autopsy data analyzed
in a standardized, comparative fashion.
Supporting Information
Table S1. ICD-10 Codes for Cause-of-Death Categories Used in This
Study
Found at doi:10.1371/journal.pmed.0040326.st001 (19 KB XLS)
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Population CSMF from Hospital DataEditors’ Summary
Background. Governments and international health agencies need
accurate information on the leading causes of death in different
populations to help them develop and monitor effective health policies
and programs. It is pointless investing money in screening programs for
a type of cancer in a country where that cancer is very rare, for example,
or setting up treatment centers for an infectious disease in a region
where the disease no longer occurs. In developed countries, most deaths
are recorded in vital registration (VR) systems. These databases record
the specific cause of death, which is assigned by doctors using the
International Classification of Diseases (ICD), an internationally agreed-
upon list of codes for hundreds of diseases. Across the developing world,
however, only one death in four is recorded by VR systems; in some very
poor countries, only one death in 20 is recorded accurately. With this
paucity of cause-of-death data, developing countries cannot make good
decisions about how to spend their limited resources.
Why Was This Study Done? The establishment of full VR systems in all
developing countries will take time and may not always be possible, but
many of these nations already collect ICD-coded data on in-hospital
deaths. Unfortunately, this information does not accurately reflect the
causes of death across whole populations. For example, the diseases that
affect rich people differ from those that affect poor people, and rich
people are more likely to die in hospital than poor people. Thus,
although for each cause of death, the number of deaths in hospital
equals the total number of deaths in the community multiplied by the
proportion of deaths occurring in hospital, this proportion is different for
each cause. If these proportions could be estimated, then in-hospital
death records could be used to determine the fraction of the population
that dies from each cause—the population’s ‘‘cause-specific mortality
fractions’’ (CSMFs). In this study, the researchers have devised a method
that allows them to do this, and have used near-complete VR data
collected between 1998 and 2005 in Mexico to test their method.
What Did the Researchers Do and Find? The researchers developed a
mathematical method that estimates the proportion of deaths occurring
in hospitals for people grouped together by their age, sex, and cause of
death (an ‘‘age–sex–cause group’’) using VR data from a subset of the
whole population. They tested their method for 45 nonoverlapping but
all-encompassing diseases using the Mexican VR data (which records
when a person has died in the hospital). They found that if they
decreased the amount of VR data used to estimate the proportion of
each age, sex, cause group dying in hospital from 100% to 9%, the
maximum relative error between the true and estimated CSMFs was only
12%. When they just used the VR information from the capital city (9% of
the population), the average relative error in CSMFs (a measure of how
much the estimated and true CSMFs differ) across all 45 causes of death
was only 10%. Finally, when they used VR data for the main urban area of
Mexico (where access to hospitals is good) to estimate CSMFs for the
three least developed states of Mexico, the average relative errors were
20%, 23%, and 31%.
What Do These Findings Mean? These findings indicate that the
researchers’ method can provide accurate estimates of population
CSMFs using ICD-coded cause-of-death data from deaths in hospital and
VR data that cover part of the population. Even when the VR data from a
developed area are used to calculate the CSMFs in a poorly developed
area, the method produces a more accurate estimate than in-hospital
death data used alone. Because the researchers have only tested their
method for one country, additional ‘‘validation studies’’ need to be done
using data from other countries with a good-quality VR system. If the
method does work in these other settings, then existing data on in-
hospital deaths could be used to determine the leading causes of death
in countries with poor VR systems. Such information would be invaluable
in establishing effective health policies.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040326.
  An accompanying paper by the same authors describes an alternative
approach to collecting accurate cause-of-death data in developing
countries
  The World Health Organization provides information on health
statistics and health information systems, on the International
Classification of Diseases, and on the Health Metrics Network, a global
collaboration focused on improving sources of vital statistics and
cause-of-death data
  Grand Challenges in Global Health provides information on research
into better ways for developing countries to measure their health
status
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